Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah J Storr

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Investigational New Drugs|March 26, 2021
Cytotoxic and radiosensitising effects of a novel thioredoxin reductase inhibitor in breast cancerNurul A Abdullah, Martyn Inman, Christopher J Moody, et al.
Molecular Neurobiology|March 28, 2022
Cytotoxic and Radiosensitising Effects of a Novel Thioredoxin Reductase Inhibitor in Brain CancersAnqi Yao, Sarah J Storr, Martyn Inman, et al.
Frontiers in Physiology|November 19, 2021
Transcription Factor Control of Lymphatic Quiescence and Maturation of Lymphatic Neovessels in Development and PhysiologyZarah B Tabrizi, Nada S Ahmed, Joseph L Horder, et al.
Journal of Cellular and Molecular Medicine|September 9, 2023
High BMP7 expression is associated with poor prognosis in ovarian cancerRicha Vasan, Jahnavi Yadav, Radhika Aiyappa-Maudsley, et al.
Expert Review of Anticancer Therapy|August 24, 2006
Use of autoantibodies in breast cancer screening and diagnosisSarah J Storr, Jayeta Chakrabarti, Anthony Barnes, et al.
Cancer Immunology, Immunotherapy : CII|May 29, 2017
Macrophage-derived interleukin-1beta promotes human breast cancer cell migration and lymphatic adhesion in vitroSarah J Storr, Sabreena Safuan, Narmeen Ahmad, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 7, 2011
Expression of thioredoxin system and related peroxiredoxin proteins is associated with clinical outcome in radiotherapy treated early stage breast cancerCaroline M Woolston, Sarah J Storr, Ian O Ellis, et al.
Diseases (Basel, Switzerland)|October 25, 2024
Thioredoxin System Protein Expression in Carcinomas of the Pancreas, Distal Bile Duct, and Ampulla in the United KingdomKhaled S Al-Hadyan, Sarah J Storr, Abed M Zaitoun, et al.
Journal of Cellular and Molecular Medicine|May 1, 2020
Retrospective assessment of cyclin-dependent kinase 5 mRNA and protein expression and its association with patient survival in breast cancerBehnaz Saidy, Emad A Rakha, Andrew R Green, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2017
IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patientsNarmeen Ahmad, Aula Ammar, Sarah J Storr, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Investigational New Drugs|March 26, 2021
Cytotoxic and radiosensitising effects of a novel thioredoxin reductase inhibitor in breast cancerNurul A Abdullah, Martyn Inman, Christopher J Moody, et al.
Molecular Neurobiology|March 28, 2022
Cytotoxic and Radiosensitising Effects of a Novel Thioredoxin Reductase Inhibitor in Brain CancersAnqi Yao, Sarah J Storr, Martyn Inman, et al.
Frontiers in Physiology|November 19, 2021
Transcription Factor Control of Lymphatic Quiescence and Maturation of Lymphatic Neovessels in Development and PhysiologyZarah B Tabrizi, Nada S Ahmed, Joseph L Horder, et al.
Journal of Cellular and Molecular Medicine|September 9, 2023
High BMP7 expression is associated with poor prognosis in ovarian cancerRicha Vasan, Jahnavi Yadav, Radhika Aiyappa-Maudsley, et al.
Expert Review of Anticancer Therapy|August 24, 2006
Use of autoantibodies in breast cancer screening and diagnosisSarah J Storr, Jayeta Chakrabarti, Anthony Barnes, et al.
Cancer Immunology, Immunotherapy : CII|May 29, 2017
Macrophage-derived interleukin-1beta promotes human breast cancer cell migration and lymphatic adhesion in vitroSarah J Storr, Sabreena Safuan, Narmeen Ahmad, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 7, 2011
Expression of thioredoxin system and related peroxiredoxin proteins is associated with clinical outcome in radiotherapy treated early stage breast cancerCaroline M Woolston, Sarah J Storr, Ian O Ellis, et al.
Diseases (Basel, Switzerland)|October 25, 2024
Thioredoxin System Protein Expression in Carcinomas of the Pancreas, Distal Bile Duct, and Ampulla in the United KingdomKhaled S Al-Hadyan, Sarah J Storr, Abed M Zaitoun, et al.
Journal of Cellular and Molecular Medicine|May 1, 2020
Retrospective assessment of cyclin-dependent kinase 5 mRNA and protein expression and its association with patient survival in breast cancerBehnaz Saidy, Emad A Rakha, Andrew R Green, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2017
IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patientsNarmeen Ahmad, Aula Ammar, Sarah J Storr, et al.
Pageof 6